Anti-IL1 in patients with low penetrance mutations for autoinflammatory diseases: tuscany and sicilian case series from paediatric to adult age

Giovanni Corsello; Maria Cristina Maggio; Umberto Corpora

Anti-IL1 in patients with low penetrance mutations for autoinflammatory diseases: tuscany and sicilian case series from paediatric to adult age

Giovanni Corsello, Maria Cristina Maggio, Umberto Corpora

Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza “G. D’Alessandro”

Risultato della ricerca: Meeting Abstract › peer review

Abstract

Patients with low penetrance mutations for Autoinflammatory syndromes (AID) can have severe clinical manifestations, which require to be treated with biological drugs anti-IL-1. Objectives: To evaluate the response of AID to treatment with the recombinant human IL-1 receptor antagonist anakinra or with the anti-IL-1b.

Lingua originale	English
pagine (da-a)	104-104
Numero di pagine	1
Rivista	PEDIATRIC RHEUMATOLOGY ONLINE JOURNAL
Volume	15
Stato di pubblicazione	Published - 2017

Altri file e collegamenti

OA Link

Cita questo

@article{165973b3211b49319e762bb7becace11,

title = "Anti-IL1 in patients with low penetrance mutations for autoinflammatory diseases: tuscany and sicilian case series from paediatric to adult age",

abstract = "Patients with low penetrance mutations for Autoinflammatory syndromes (AID) can have severe clinical manifestations, which require to be treated with biological drugs anti-IL-1. Objectives: To evaluate the response of AID to treatment with the recombinant human IL-1 receptor antagonist anakinra or with the anti-IL-1b.",

author = "Giovanni Corsello and Maggio, {Maria Cristina} and Umberto Corpora",

year = "2017",

language = "English",

volume = "15",

pages = "104--104",

journal = "Pediatric Rheumatology",

issn = "1546-0096",

publisher = "BioMed Central Ltd.",

}

TY - JOUR

T1 - Anti-IL1 in patients with low penetrance mutations for autoinflammatory diseases: tuscany and sicilian case series from paediatric to adult age

AU - Corsello, Giovanni

AU - Maggio, Maria Cristina

AU - Corpora, Umberto

PY - 2017

Y1 - 2017

N2 - Patients with low penetrance mutations for Autoinflammatory syndromes (AID) can have severe clinical manifestations, which require to be treated with biological drugs anti-IL-1. Objectives: To evaluate the response of AID to treatment with the recombinant human IL-1 receptor antagonist anakinra or with the anti-IL-1b.

AB - Patients with low penetrance mutations for Autoinflammatory syndromes (AID) can have severe clinical manifestations, which require to be treated with biological drugs anti-IL-1. Objectives: To evaluate the response of AID to treatment with the recombinant human IL-1 receptor antagonist anakinra or with the anti-IL-1b.

UR - http://hdl.handle.net/10447/390109

M3 - Meeting Abstract

SN - 1546-0096

VL - 15

SP - 104

EP - 104

JO - Pediatric Rheumatology

JF - Pediatric Rheumatology

ER -

Anti-IL1 in patients with low penetrance mutations for autoinflammatory diseases: tuscany and sicilian case series from paediatric to adult age

Abstract

Altri file e collegamenti

Fingerprint

Cita questo